DRUG SURVIVAL OF A PATIENTS COHORT WITH CHRONIC INFLAMMATORY RHEUMATISM TREATED WITH ABATACEPT

被引：0
作者：
Bello, S. [1 ]
Fanizzi, R. [1 ]
Rotondo, C. [1 ]
Rinaldi, A. [1 ]
Dinoia, L. [1 ]
Lopriore, S. [1 ]
Serafino, L. [1 ]
Bonali, C. [1 ]
Lannone, F. [1 ]
Lapadula, G. [1 ]
机构：
[1] Univ Bari, Policlin Hosp, Rheumatol Unit, Bari, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.2669
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0448
引用
收藏
页码：956 / 956
页数：1
相关论文
共 50 条
  • [41] Drug Survival and Predictors of Drug Survival for Methotrexate Treatment in a Retrospective Cohort of Adult Patients with Localized Scleroderma
    Mertens, Jorre S.
    van den Reek, Juul M.
    Kievit, Wietske
    van de Kerkhof, Peter C. M.
    Thurlings, Rogier M.
    Radstake, Tim R. D.
    Seyger, Marieke M. B.
    de Jong, Elke M. G. J.
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (07) : 943 - 947
  • [42] Cutaneous manifestations of monogenic auto-inflammatory diseases: An international cohort study from the Juvenile Inflammatory Rheumatism cohort
    Monfort, J. B.
    Deshayes, S.
    Dusser, P.
    Bourguiba, R.
    Savey, L.
    Vinit, C.
    Kone-Paut, I.
    Amaryan, G.
    Theodoropoulou, K.
    Guedri, R.
    Pachlopnik, J.
    Belot, A.
    Melki, I.
    Maldar, N. Perveen
    Hentgen, V.
    Georgin-Lavialle, S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (06) : 1391 - 1394
  • [43] EVALUATION OF THE NOCEBO EFFECT WHEN SWITCHING FROM THE ORIGINATOR MOLECULE TO A BIOSIMILAR IN A NORMANDY RETROSPECTIVE COHORT OF PATIENTS WITH INFLAMMATORY RHEUMATISM TREATED WITH ETANERCEPT OR ADALIMUMAB (BIONORIC STUDY)
    Hagege, O.
    Lequerre, T.
    Marcelli, C.
    Varin, R.
    Alcaix, D.
    Weber, A. J.
    Mihailescu, S. D.
    Duhamel, E.
    Vittecoq, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 2042 - 2042
  • [44] RISK OF ACUTE LEUCOSIS AFTER TREATMENT OF CHRONIC INFLAMMATORY RHEUMATISM AND CONNECTIVITIES WITH CYTOTOXIC DRUGS WITH IMMUNOSUPPRESSIVE PROPERTIES - RESULTS OF A RETROSPECTIVE STUDY OF 2006 PATIENTS TREATED
    KAHN, MF
    ARLET, J
    BLOCHMICHEL, H
    CAROIT, M
    CHAOUAT, Y
    RENIER, JC
    REVUE DU RHUMATISME, 1979, 46 (03): : 163 - 167
  • [45] Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics
    Deyhim, Tina
    Cheifetz, Adam S.
    Papamichael, Konstantinos
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
  • [46] Drug Survival in Patients with Inflammatory Bowel disease: An observational study
    Kubesch, A.
    Grimm, L.
    Stratmann, K.
    Knabe, M.
    Filmann, N.
    Sprinzl, K.
    Hausmann, J.
    Blumenstein, I.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S517 - S517
  • [47] Abatacept-Treated Rheumatoid Arthritis Patients Have Better Drug-Survival Rate When Abatacept Is the First or Second Line Biologic Agent with an Excellent Overall Safety Profile: A Single Center Experience
    Flouri, Irini
    Repa, Argyro
    Fanouriakis, Antonis
    Kougkas, Nikolaos
    Papalopoulos, Ioannis
    Kampouraki, Eleni
    Boumpas, Dimitrios
    Avgoustidis, Nestor
    Bertsias, George
    Sidiropoulos, Prodromos
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [48] Similar Short Term Survival on Drug for Patients with Rheumatoid Arthritis Treated with Subcutaneous and Intravenous Abatacept Results from the National Swedish Rheumatology Quality Register.
    Turesson, Carl
    Stawiarz, Leszek
    Lindblad, Staffan
    Saevarsdottir, Saedis
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S221 - S221
  • [49] Predictors of long-term survival in elderly patients with chronic angina treated with optimized drug therapy or revascularization
    Pfisterer, M
    Kaiser, C
    Jeger, R
    Bonetti, PO
    Rickenbacher, P
    Osswald, S
    Buser, P
    EUROPEAN HEART JOURNAL, 2004, 25 : 440 - 440
  • [50] PATIENTS WITH COXARTHROSIS TREATED IN RHEUMATISM COUNSELING OFFICES IN POLAND
    TEMPSKACYRANKIEWICZ, K
    AKTUELLE RHEUMATOLOGIE, 1987, 12 (03) : 190 - 190
12345